Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion

@article{Bare2015TreatmentOL,
  title={Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion},
  author={Thierry de Ba{\`e}re and Yasuaki Arai and Riccardo A Lencioni and J. Geschwind and William S. Rilling and Riad Salem and Osamu Matsui and Michael C. Soulen},
  journal={CardioVascular and Interventional Radiology},
  year={2015},
  volume={39},
  pages={334-343}
}
Transarterial chemoembolization with Lipiodol (Lipiodol TACE), also called conventional TACE, was developed in the early 1980s and widely adopted worldwide after randomized control trials and meta-analysis demonstrated superiority of Lipiodol TACE to best supportive care. Presently, there is no level one evidence that other TACE techniques are superior to Lipiodol TACE for intermediate stage hepatocellular carcinoma (HCC), which includes patients with preserved liver function and nonsurgical… CONTINUE READING